Table of Contents Global Nanomedicine Market Professional Survey Report 2017 1 Industry Overview of Nanomedicine 1.1 Definition and Specifications of Nanomedicine 1.1.1 Definition of Nanomedicine 1.1.2 Specifications of Nanomedicine 1.2 Classification of Nanomedicine 1.2.1 Global Nanomedicine Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) 1.2.2 Global Nanomedicine Production Market Share (%) by Types in 2017 1.2.3 Regenerative Medicine 1.2.4 In-vitro & In-vivo Diagnostics 1.2.5 Vaccines 1.2.6 Drug Delivery 1.3 Applications of Nanomedicine 1.3.1 Global Nanomedicine Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 Clinical Cardiology 1.3.3 Urology 1.3.4 Genetics 1.3.5 Orthopedics 1.3.6 Ophthalmology 1.4 Global NanomedicineMarket by Regions (2012-2023) 1.4.1 Global Nanomedicine Market Size and Growth Rate (%) Comparison by Regions (2012-2023) 1.4.2 North AmericaNanomedicine Status and Prospect (2012-2023) 1.4.3 EuropeNanomedicine Status and Prospect (2012-2023) 1.4.4 ChinaNanomedicine Status and Prospect (2012-2023) 1.4.5 JapanNanomedicine Status and Prospect (2012-2023) 1.4.6 Southeast AsiaNanomedicine Status and Prospect (2012-2023) 1.5 Global Nanomedicine Market Size (2012-2023) 1.5.1 Global Nanomedicine Revenue (Million USD) Status and Outlook (2012-2023) 1.5.2 Global Nanomedicine Capacity, Production (K Units) Status and Outlook (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Nanomedicine 2.2 Raw Material Analysis of Nanomedicine 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Nanomedicine 2.4 Other Costs Analysis of Nanomedicine 2.5 Manufacturing Cost Structure Analysis of Nanomedicine 2.6 Manufacturing Process Analysis of Nanomedicine 2.7 Raw Materials Sources of Nanomedicine Major Manufacturers in 2017 2.8 Downstream Buyers of Nanomedicine 3 Global Nanomedicine Manufacturers Profiles/Analysis 3.1 GE Healthcare 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Nanomedicine Product Category, Application and Specification 3.1.2.1 Regenerative Medicine 3.1.2.2 In-vitro & In-vivo Diagnostics 3.1.2.3 Vaccines 3.1.3 GE Healthcare 2017 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.1.4 GE Healthcare 2017 Business Region Distribution Analysis 3.1.5 GE Healthcare Nanomedicine Volume in Different Applications and Its Application Share 3.2 Johnson & Johnson 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Nanomedicine Product Category, Application and Specification 3.2.2.1 Regenerative Medicine 3.2.2.2 In-vitro & In-vivo Diagnostics 3.2.2.3 Vaccines 3.2.3 Johnson & Johnson 2017 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.2.4 Johnson & Johnson 2017 Business Region Distribution Analysis 3.2.5 Johnson & Johnson Nanomedicine Volume in Different Applications and Its Application Share 3.3 Mallinckrodt plc 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Nanomedicine Product Category, Application and Specification 3.3.2.1 Regenerative Medicine 3.3.2.2 In-vitro & In-vivo Diagnostics 3.3.2.3 Vaccines 3.3.3 Mallinckrodt plc 2017 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.3.4 Mallinckrodt plc 2017 Business Region Distribution Analysis 3.3.5 Mallinckrodt plc Nanomedicine Volume in Different Applications and Its Application Share 3.4 Merck & Co. Inc. 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Nanomedicine Product Category, Application and Specification 3.4.2.1 Regenerative Medicine 3.4.2.2 In-vitro & In-vivo Diagnostics 3.4.2.3 Vaccines 3.4.3 Merck & Co. Inc. 2017 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.4.4 Merck & Co. Inc. 2017 Business Region Distribution Analysis 3.4.5 Merck & Co. Inc. Nanomedicine Volume in Different Applications and Its Application Share 3.5 Nanosphere Inc. 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Nanomedicine Product Category, Application and Specification 3.5.2.1 Regenerative Medicine 3.5.2.2 In-vitro & In-vivo Diagnostics 3.5.2.3 Vaccines 3.5.3 Nanosphere Inc. 2017 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.5.4 Nanosphere Inc. 2017 Business Region Distribution Analysis 3.5.5 Nanosphere Inc. Nanomedicine Volume in Different Applications and Its Application Share 3.6 Pfizer Inc. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Nanomedicine Product Category, Application and Specification 3.6.2.1 Regenerative Medicine 3.6.2.2 In-vitro & In-vivo Diagnostics 3.6.2.3 Vaccines 3.6.3 Pfizer Inc. Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.6.4 Pfizer Inc. 2017 Business Region Distribution Analysis 3.6.5 Pfizer Inc. Nanomedicine Volume in Different Applications and Its Application Share 3.7 Sigma-Tau Pharmaceuticals Inc. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Nanomedicine Product Category, Application and Specification 3.7.2.1 Regenerative Medicine 3.7.2.2 In-vitro & In-vivo Diagnostics 3.7.2.3 Vaccines 3.7.3 Sigma-Tau Pharmaceuticals Inc. 2017 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.7.4 Sigma-Tau Pharmaceuticals Inc. 2017 Business Region Distribution Analysis 3.7.5 Sigma-Tau Pharmaceuticals Inc. Nanomedicine Volume in Different Applications and Its Application Share 3.8 Smith & Nephew PLC 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Nanomedicine Product Category, Application and Specification 3.8.2.1 Regenerative Medicine 3.8.2.2 In-vitro & In-vivo Diagnostics 3.8.2.3 Vaccines 3.8.3 Smith & Nephew PLC 2017 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.8.4 Smith & Nephew PLC 2017 Business Region Distribution Analysis 3.8.5 Smith & Nephew PLC Nanomedicine Volume in Different Applications and Its Application Share 3.9 Stryker Corp 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Nanomedicine Product Category, Application and Specification 3.9.2.1 Regenerative Medicine 3.9.2.2 In-vitro & In-vivo Diagnostics 3.9.2.3 Vaccines 3.9.3 Stryker Corp 2017 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.9.4 Stryker Corp 2017 Business Region Distribution Analysis 3.9.5 Stryker Corp Nanomedicine Volume in Different Applications and Its Application Share 3.10 Teva Pharmaceutical Industries Ltd. 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Nanomedicine Product Category, Application and Specification 3.10.2.1 Regenerative Medicine 3.10.2.2 In-vitro & In-vivo Diagnostics 3.10.2.3 Vaccines 3.10.3 Teva Pharmaceutical Industries Ltd. 2017 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.10.4 Teva Pharmaceutical Industries Ltd. 2017 Business Region Distribution Analysis 3.10.5 Teva Pharmaceutical Industries Ltd. Nanomedicine Volume in Different Applications and Its Application Share 3.11 UCB (Union chimique belge) S.A 4 Technical Data and Manufacturing Plants Analysis of Nanomedicine 4.1 Capacity and Commercial Production Date of Global Nanomedicine Major Manufacturers in 2017 4.2 Manufacturing Plants Distribution of Global Nanomedicine Major Manufacturers in 2017 4.4 R&D Status and Technology Source of Global Nanomedicine Major Manufacturers in 2017 4.4 Raw Materials Sources Analysis of Global Nanomedicine Major Manufacturers in 2017 5 Global Nanomedicine Overall Market Overview 5.1 2012-2017 Overall Market Analysis 5.2 Capacity Analysis 5.2.1 2012-2017 Global Nanomedicine Capacity and Growth Rate Analysis 5.2.2 2017 Nanomedicine Capacity Analysis (Company Segment) 5.3 Sales Analysis 5.3.1 2012-2017 Global Nanomedicine Sales and Growth Rate Analysis 5.3.2 2017 Nanomedicine Sales Analysis (Company Segment) 5.4 Sales Price Analysis 5.4.1 2012-2017 Global Nanomedicine Sales Price 5.4.2 2017 Nanomedicine Sales Price Analysis (Company Segment) 6 Nanomedicine Regional Market Analysis 6.1 North America Nanomedicine Market Analysis 6.1.1 North America Nanomedicine Market Overview 6.1.2 North America 2012-2017 Nanomedicine Local Supply, Import, Export, Local Consumption Analysis 6.1.3 North America 2012-2017 Nanomedicine Sales Price Analysis 6.1.4 North America 2017 Nanomedicine Market Share Analysis 6.2 Europe Nanomedicine Market Analysis 6.2.1 Europe Nanomedicine Market Overview 6.2.2 Europe 2012-2017 Nanomedicine Local Supply, Import, Export, Local Consumption Analysis 6.2.3 Europe 2012-2017 Nanomedicine Sales Price Analysis 6.2.4 Europe 2017 Nanomedicine Market Share Analysis 6.3 China Nanomedicine Market Analysis 6.3.1 China Nanomedicine Market Overview 6.3.2 China 2012-2017 Nanomedicine Local Supply, Import, Export, Local Consumption Analysis 6.3.3 China 2012-2017 Nanomedicine Sales Price Analysis 6.3.4 China 2017 Nanomedicine Market Share Analysis 6.4 Japan Nanomedicine Market Analysis 6.4.1 Japan Nanomedicine Market Overview 6.4.2 Japan 2012-2017 Nanomedicine Local Supply, Import, Export, Local Consumption Analysis 6.4.3 Japan 2012-2017 Nanomedicine Sales Price Analysis 6.4.4 Japan 2017 Nanomedicine Market Share Analysis 6.5 Southeast Asia Nanomedicine Market Analysis 6.5.1 Southeast Asia Nanomedicine Market Overview 6.5.2 Southeast Asia 2012-2017 Nanomedicine Local Supply, Import, Export, Local Consumption Analysis 6.5.3 Southeast Asia 2012-2017 Nanomedicine Sales Price Analysis 6.5.4 Southeast Asia 2017 Nanomedicine Market Share Analysis 6.6 India Nanomedicine Market Analysis 6.6.1 India Nanomedicine Market Overview 6.6.2 India 2012-2017 Nanomedicine Local Supply, Import, Export, Local Consumption Analysis 6.6.3 India 2012-2017 Nanomedicine Sales Price Analysis 6.6.4 India 2017 Nanomedicine Market Share Analysis 7 Global 2012-2017 Nanomedicine Segment Market Analysis (by Type) 7.1 Global 2012-2017 Nanomedicine Sales by Type 7.2 Different Types of Nanomedicine Product Interview Price Analysis 7.3 Different Types of Nanomedicine Product Driving Factors Analysis 7.3.1 Regenerative Medicine of Nanomedicine Growth Driving Factor Analysis 7.3.2 In-vitro & In-vivo Diagnostics of Nanomedicine Growth Driving Factor Analysis 7.3.3 Vaccines of Nanomedicine Growth Driving Factor Analysis 7.3.4 Drug Delivery of Nanomedicine Growth Driving Factor Analysis 8 Global 2012-2017 Nanomedicine Segment Market Analysis (by Application) 8.1 Global 2012-2017 Nanomedicine Consumption by Application 8.2 Different Application of Nanomedicine Product Interview Price Analysis 8.3 Different Application of Nanomedicine Product Driving Factors Analysis 8.3.1 Clinical Cardiology of Nanomedicine Growth Driving Factor Analysis 8.3.2 Urology of Nanomedicine Growth Driving Factor Analysis 8.3.3 Genetics of Nanomedicine Growth Driving Factor Analysis 8.3.4 Orthopedics of Nanomedicine Growth Driving Factor Analysis 8.3.5 Ophthalmology of Nanomedicine Growth Driving Factor Analysis 9 Development Trend of Analysis of Nanomedicine Market 9.1 Global Nanomedicine Market Trend Analysis 9.1.1 Global 2018-2023 Nanomedicine Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2023 Nanomedicine Sales Price Forecast 9.2 Nanomedicine Regional Market Trend 9.2.1 North America 2018-2023 Nanomedicine Consumption Forecast 9.2.2 Europe 2018-2023 Nanomedicine Consumption Forecast 9.2.3 China 2018-2023 Nanomedicine Consumption Forecast 9.2.4 Japan 2018-2023 Nanomedicine Consumption Forecast 9.2.5 Southeast Asia 2018-2023 Nanomedicine Consumption Forecast 9.2.6 India 2018-2023 Nanomedicine Consumption Forecast 9.3 Nanomedicine Market Trend (Product Type) 9.4 Nanomedicine Market Trend (Application) 10 Marketing Strategy Analysis, Distributors/Traders 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List 11 Nanomedicine Marketing Type Analysis 11.1 Nanomedicine Regional Marketing Type Analysis 11.2 Nanomedicine International Trade Type Analysis 11.3 Traders or Distributors with Contact Information of Nanomedicine by Region 11.4 Nanomedicine Supply Chain Analysis 12 Consumers Analysis of Nanomedicine 12.1 Consumer 1 Analysis 12.2 Consumer 2 Analysis 12.3 Consumer 3 Analysis 12.4 Consumer 4 Analysis 13 Conclusion of the Global Nanomedicine Market Professional Survey Report 2018 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Market Size (Million USD) Status and Outlook 2012-2023 Table Global Nanomedicine Revenue (Million USD) Comparison by Regions (2012-2023) Table Global Nanomedicine Production (K Units) and Revenue (Million USD) Market Split by Product Type Table Global Nanomedicine Consumption (K Units) by Application (2016-2023) Figure Picture of Nanomedicine Table Product Specifications of Nanomedicine Table Global Nanomedicine Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Global Nanomedicine Production Market Share (%) by Types in 2017 Figure Regenerative Medicine Picture Table Major Manufacturers of Regenerative Medicine Figure In-vitro & In-vivo Diagnostics Picture Table Major Manufacturers of In-vitro & In-vivo Diagnostics Figure Vaccines Picture Table Major Manufacturers of Vaccines Table Global Nanomedicine Consumption (K Units) Comparison by Applications (2012-2023) Figure Global Nanomedicine Consumption (K Units) Market Share (%) by Applications in 2017 Figure Clinical Cardiology Picture Figure Urology Picture Figure Genetics Picture Table Global Nanomedicine Revenue (Million USD) Comparison by Regions (2012-2023) Figure North America Nanomedicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Nanomedicine Revenue (Million USD) and Growth Rate (2012-2023) Figure China Nanomedicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Nanomedicine Revenue (Million USD) and Growth Rate (2012-2023) Figure India Nanomedicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Nanomedicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Global Nanomedicine Revenue (Million USD) Status and Outlook (2012-2023) Figure Global Nanomedicine Capacity, Production (K Units) Status and Outlook (2012-2023) Figure Industry Chain Structure of Nanomedicine Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Nanomedicine in 2017 Figure Manufacturing Process Analysis of Nanomedicine Table Raw Materials Sources of Nanomedicine Major Manufacturers in 2017 Table Major Buyers of Nanomedicine Table GE Healthcare Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table Vaccines Nanomedicine Overview Table 2017 GE Healthcare Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 GE Healthcare Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GE Healthcare Nanomedicine Volume in Clinical Cardiology and Its Application Share Table GE Healthcare Nanomedicine Volume in Urology and Its Application Share Table GE Healthcare Nanomedicine Volume in Genetics and Its Application Share Table Johnson & Johnson Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table Vaccines Nanomedicine Overview Table 2017 Johnson & Johnson Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 Johnson & Johnson Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson Nanomedicine Volume in Clinical Cardiology and Its Application Share Table Johnson & Johnson Nanomedicine Volume in Urology and Its Application Share Table Johnson & Johnson Nanomedicine Volume in Genetics and Its Application Share Table Mallinckrodt plc Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table 2017 Mallinckrodt plc Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 Mallinckrodt plc Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Mallinckrodt plc Nanomedicine Volume in Clinical Cardiology and Its Application Share Table Mallinckrodt plc Nanomedicine Volume in Urology and Its Application Share Table Mallinckrodt plc Nanomedicine Volume in Genetics and Its Application Share Table Merck & Co. Inc. Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table Vaccines Nanomedicine Overview Table 2017 Merck & Co. Inc. Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 Merck & Co. Inc. Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck & Co. Inc. Nanomedicine Volume in Clinical Cardiology and Its Application Share Table Merck & Co. Inc. Nanomedicine Volume in Urology and Its Application Share Table Merck & Co. Inc. Nanomedicine Volume in Genetics and Its Application Share Table Nanosphere Inc. Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table 2017 Nanosphere Inc. Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 Nanosphere Inc. Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nanosphere Inc. Nanomedicine Volume in Clinical Cardiology and Its Application Share Table Nanosphere Inc. Nanomedicine Volume in Urology and Its Application Share Table Nanosphere Inc. Nanomedicine Volume in Genetics and Its Application Share Table Pfizer Inc. Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table 2017 Pfizer Inc. Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 Pfizer Inc. Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Inc. Nanomedicine Volume in Clinical Cardiology and Its Application Share Table Pfizer Inc. Nanomedicine Volume in Urology and Its Application Share Table Pfizer Inc. Nanomedicine Volume in Genetics and Its Application Share Table Sigma-Tau Pharmaceuticals Inc. Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table 2017 Sigma-Tau Pharmaceuticals Inc. Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 Sigma-Tau Pharmaceuticals Inc. Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sigma-Tau Pharmaceuticals Inc. Nanomedicine Volume in Urology and Its Application Share Table Sigma-Tau Pharmaceuticals Inc. Nanomedicine Volume in Genetics and Its Application Share Table Smith & Nephew PLC Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table 2017 Smith & Nephew PLC Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 Smith & Nephew PLC Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Smith & Nephew PLC Nanomedicine Volume in Clinical Cardiology and Its Application Share Table Smith & Nephew PLC Nanomedicine Volume in Urology and Its Application Share Table Smith & Nephew PLC Nanomedicine Volume in Genetics and Its Application Share Table Stryker Corp Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table 2017 Stryker Corp Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 Stryker Corp Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Stryker Corp Nanomedicine Volume in Clinical Cardiology and Its Application Share Table Stryker Corp Nanomedicine Volume in Urology and Its Application Share Table Stryker Corp Nanomedicine Volume in Genetics and Its Application Share Table Teva Pharmaceutical Industries Ltd. Information List Table Regenerative Medicine Nanomedicine Overview Table In-vitro & In-vivo Diagnostics Nanomedicine Overview Table 2017 Teva Pharmaceutical Industries Ltd. Nanomedicine Revenue, Sales, Ex-factory Price Figure 2017 Teva Pharmaceutical Industries Ltd. Nanomedicine Business Region Distribution Table Regenerative Medicine Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table In-vitro & In-vivo Diagnostics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Teva Pharmaceutical Industries Ltd. Nanomedicine Volume in Clinical Cardiology and Its Application Share Table Teva Pharmaceutical Industries Ltd. Nanomedicine Volume in Urology and Its Application Share Table Teva Pharmaceutical Industries Ltd. Nanomedicine Volume in Genetics and Its Application Share Table Capacity (K Units) and Commercial Production Date of Global Nanomedicine Major Manufacturers in 2017 Table Manufacturing Plants Distribution of Global Nanomedicine Major Manufacturers in 2017 Table R&D Status and Technology Source of Global Nanomedicine Major Manufacturers in 2017 Table Raw Materials Sources Analysis of Global Nanomedicine Major Manufacturers in 2017 Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Nanomedicine 2012-2017 Figure Global 2012-2017 Nanomedicine Sales (K Units) and Growth Rate Figure Global 2012-2017 Nanomedicine Market Size (Million USD) and Growth Rate Figure 2012-2017 Global Nanomedicine Capacity and Growth Rate Table 2017 Global Nanomedicine Capacity List (Company Segment) Figure 2012-2017 Global Nanomedicine Sales and Growth Rate Table 2017 Global Nanomedicine Sales List (Company Segment) Figure 2012-2017 Global Nanomedicine Sales Price Table 2017 Global Nanomedicine Sales Price List (Company Segment) Figure North America Capacity Overview Figure North America 2017 Nanomedicine Capacity Market Share Table North America Supply, Import, Export and Consumption of Nanomedicine 2012-2017 (K Units) Figure North America 2012-2017 Nanomedicine Sales Price (USD/Unit) Figure North America 2017 Nanomedicine Sales Market Share Figure Europe Capacity Overview Figure Europe 2017 Nanomedicine Capacity Market Share Table Europe Supply, Import, Export and Consumption of Nanomedicine 2012-2017 (K Units) Figure Europe 2012-2017 Nanomedicine Sales Price (USD/Unit) Figure North America 2017 Nanomedicine Sales Market Share Figure China Capacity Overview Figure China 2017 Nanomedicine Capacity Market Share Table China Supply, Import, Export and Consumption of Nanomedicine 2012-2017 (K Units) Figure China 2012-2017 Nanomedicine Sales Price (USD/Unit) Figure China 2017 Nanomedicine Sales Market Share Figure Japan Capacity Overview Figure Japan 2017 Nanomedicine Capacity Market Share Table Japan Supply, Import, Export and Consumption of Nanomedicine 2012-2017 (K Units) Figure Japan 2012-2017 Nanomedicine Sales Price (USD/Unit) Figure Japan 2017 Nanomedicine Sales Market Share Figure Southeast Asia Capacity Overview Figure Southeast Asia 2017 Nanomedicine Capacity Market Share Table Southeast Asia Supply, Import, Export and Consumption of Nanomedicine 2012-2017 (K Units) Figure Southeast Asia 2012-2017 Nanomedicine Sales Price (USD/Unit) Figure Southeast Asia 2017 Nanomedicine Sales Market Share Figure India Capacity Overview Figure India 2017 Nanomedicine Capacity Market Share Table India Supply, Import, Export and Consumption of Nanomedicine 2012-2017 (K Units) Figure India 2012-2017 Nanomedicine Sales Price (USD/Unit) Figure India 2017 Nanomedicine Sales Market Share Table Global 2012-2017 Nanomedicine Sales by Type Table Different Types Nanomedicine Product Interview Price Table Global 2012-2017 Nanomedicine Sales by Application Table Different Application Nanomedicine Product Interview Price Figure Global 2018-2023 Nanomedicine Sales (K Units) and Growth Rate Forecast Figure Global 2018-2023 Nanomedicine Market Size (Million USD) and Growth Rate Forecast Figure Global 2018-2023 Nanomedicine Sales Price (USD/Unit) Forecast Figure North America 2018-2023 Nanomedicine Consumption Volume and Growth Rate Forecast Figure Europe 2018-2023 Nanomedicine Consumption Volume and Growth Rate Forecast Figure China 2018-2023 Nanomedicine Consumption Volume and Growth Rate Forecast Figure Japan 2018-2023 Nanomedicine Consumption Volume and Growth Rate Forecast Figure Southeast Asia 2018-2023 Nanomedicine Consumption Volume and Growth Rate Forecast Figure India 2018-2023 Nanomedicine Consumption Volume and Growth Rate Forecast Table Global Sales Volume (K Units) of Nanomedicine by In-vitro & In-vivo Diagnostics2018-2023 Table Global Consumption Volume (K Units) of Nanomedicine by Urology2018-2023 Table Distributors/Traders List Table Traders or Distributors with Contact Information of Nanomedicine by Regions Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GE Healthcare Johnson & Johnson Mallinckrodt plc Merck & Co. Inc. Nanosphere Inc. Pfizer Inc. Sigma-Tau Pharmaceuticals Inc. Smith & Nephew PLC Stryker Corp Teva Pharmaceutical Industries Ltd. UCB (Union chimique belge) S.A